Seer Pharmaceuticals   Report issue

For profit Phase 1
Founded: Melbourne Australia (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2005
NCT00219882
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now